Ipamorelin

Source: PubChem

Peptide Sequence: Aib-His-D-2Nal-D-Phe-Lys
Molecular Formula: C₃₈H₄₉N₉O₅
Molecular Weight: 711.868 g/mol
PubChem CID: 9831659
CAS Number: 170851-70-4

Research Background

Ipamorelin has been investigated in research literature across several scientific contexts:

• Growth hormone secretagogue receptor (GHS-R1a) pharmacology — investigations into receptor binding kinetics, signal transduction, and cellular response mechanisms
• Pituitary cellular biology — studies examining anterior pituitary cell responsiveness to synthetic secretagogue peptides
• Ghrelin signaling pathway research — comparative cellular research on natural ghrelin versus synthetic GHS analogs in receptor-binding contexts
• Peptide selectivity research — analytical studies examining Ipamorelin’s selective receptor binding profile compared to other secretagogue peptides
• Structure-activity relationships — peptide chemistry research on the pentapeptide structure and modifications affecting receptor affinity

Ipamorelin is notable in research literature for its selective receptor binding profile, distinguishing it from earlier-generation growth hormone secretagogues in cellular research applications. Foundational research on the GHS-R receptor system and Ipamorelin specifically is available through PubMed (pubmed.ncbi.nlm.nih.gov) and the National Institutes of Health’s PMC database (pmc.ncbi.nlm.nih.gov), where researchers can access peer-reviewed studies including foundational work by Raun et al. and other peptide research laboratories.

Terms of Sale

This product is supplied for in vitro laboratory research only and has not been evaluated by the U.S. Food and Drug Administration. By purchasing, the buyer confirms they are 21 or older, a qualified research professional or institution, and will not use this material for human consumption, veterinary use, or any in vivo application. Peptide advantages assumes no liability for misuse or off-label application.